<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Die Vulvovaginalkandidose (außer chronisch mukokutaner Kandidose). Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (AWMF-Registernummer 015/072, S2k-Level, Dezember 2013)</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>Prof. Dr. med</roleName><surname>Diethelm Wallwiener</surname></persName>
						</author>
						<author>
							<persName><roleName>Prof. Dr</roleName><forename type="first">Matthias</forename><forename type="middle">W</forename><surname>Beckmann</surname></persName>
						</author>
						<author>
							<persName><roleName>Dr</roleName><forename type="first">Paul</forename><surname>Gaß</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Tobias</forename><surname>Brodkorb</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Marion</forename><surname>Gebhardt</surname></persName>
						</author>
						<author role="corresp">
							<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
							<email>w.mendling@t-online.de</email>
						</author>
						<author>
							<persName><forename type="first">K</forename><surname>Friese</surname></persName>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Mylonas</surname></persName>
						</author>
						<author>
							<persName><forename type="first">E.-R</forename><surname>Weissenbacher</surname></persName>
						</author>
						<author>
							<persName><forename type="first">J</forename><surname>Brasch</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Schaller</surname></persName>
						</author>
						<author>
							<persName><forename type="first">P</forename><surname>Mayser</surname></persName>
						</author>
						<author>
							<persName><forename type="first">I</forename><surname>Effendy</surname></persName>
						</author>
						<author>
							<persName><forename type="first">G</forename><surname>Ginter-Hanselmayer</surname></persName>
						</author>
						<author>
							<persName><forename type="first">H</forename><surname>Hof</surname></persName>
						</author>
						<author>
							<persName><forename type="first">O</forename><surname>Cornely</surname></persName>
						</author>
						<author>
							<persName><forename type="first">M</forename><surname>Ruhnke</surname></persName>
						</author>
						<author>
							<persName><roleName>Prof. Dr</roleName><forename type="first">Med</forename><forename type="middle">Werner</forename><surname>Mendling</surname></persName>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department">German Society for Gynaecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe [DGGG] e. V. Head Office of DGGG and Professional Societies Hausvogteiplatz</orgName>
								<address>
									<postCode>12 10117</postCode>
									<settlement>Berlin</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Universitätsfrauenklinik Tübingen Calwerstraße</orgName>
								<address>
									<postCode>72076</postCode>
									<settlement>Tübingen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="institution">Universitätsklinikum Erlangen-Nürnberg Frauenklinik Universitätsstraße</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff3">
								<orgName type="institution">Universitätsklinikum Erlangen-Nürnberg Frauenklinik Universitätsstraße</orgName>
								<address>
									<postCode>21-23 91054</postCode>
									<settlement>Erlangen</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff4">
								<orgName type="institution">Deutsches Zentrum für Infektionen in Gynäkologie und Geburtshilfe St. Anna-Klinik Vogelsangstraße</orgName>
								<address>
									<postCode>106 42109</postCode>
									<settlement>Wuppertal</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Die Vulvovaginalkandidose (außer chronisch mukokutaner Kandidose). Leitlinie der Deutschen Gesellschaft für Gynäkologie und Geburtshilfe (AWMF-Registernummer 015/072, S2k-Level, Dezember 2013)</title>
					</analytic>
					<monogr>
						<idno type="ISSN">0016-5751</idno>
					</monogr>
					<idno type="MD5">F740C7AB1885E1BD3DBB586DBFF973D3</idno>
					<idno type="DOI">10.1055/s-0035-1545741</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:28+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Candida virulence factors and other immunological experiments.</s><s>Probiotics with appropriate lactobacillus strains should also be examined in future studies on the basis of encouraging initial results.</s><s>Because of the high rate of false indications, OTC treatment (self-treatment by the patient) should be discouraged.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Methods</head><p><s>A Medline/PubMed search was conducted using the keyword "vulvovaginal candidosis" (as of 2/2010) which produced 2886 articles; a search using the keywords "vulvovaginal candidosis therapy studies" produced 237 reviews.</s><s>All were browsed according to title and abstract, however a few randomized and prospective controlled studies were left over <ref type="bibr" target="#b31">[31,</ref><ref type="bibr" target="#b43">43,</ref><ref type="bibr" target="#b70">70,</ref><ref type="bibr" target="#b108">108,</ref><ref type="bibr" target="#b134">134,</ref><ref type="bibr" target="#b145">145]</ref>.</s><s>There were only 3 metanalyses or Cochrane analyses <ref type="bibr" target="#b105">[105,</ref><ref type="bibr" target="#b150">150,</ref><ref type="bibr" target="#b159">159]</ref> and two guidelines <ref type="bibr" target="#b12">[13,</ref><ref type="bibr" target="#b82">82]</ref>.</s><s>For this revision another search was conducted using the same methods to identify articles from the last 5 years (as of 10.11.2013); this revealed 357 hits, with 44 review articles and 32 clinical studies.</s><s>Systematic evaluation of the literature and extraction into evidence tables were not performed due to this guidelineʼs classification as consensus-based.</s><s>The literature was nonetheless critically evaluated by the participating experts.</s><s>Regarding consensus, patient participation, assessment and management of potential conflicts of interest, participation of professional societies and validity, see the Guideline Report in the annex.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Guideline documents</head><p><s>The editorially complete, long version of these guidelines as well as a summary of the conflicts of interest of all the authors can be found on the homepage of AWMF: http://www.awmf.org/leitlinien/detail/ll/015-072.html</s><s>Authors See l " Table <ref type="table" target="#tab_0">1</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Summary</head><p><s>The estrogenized vagina is colonized by Candida species in at least 20 % of women; in late pregnancy and in immunosuppressed patients this increases to at least 30%.</s><s>In most cases Candida albicans is involved.</s><s>Host factors, particularly local defense mechanisms, gene polymorphisms, allergies, serum glucose levels, antibiotics, psycho-social stress and estrogens influence the risk of candidal vulvovaginitis.</s><s>Non-albicans species, particularly Candida glabrata, and in rare cases also Saccharomyces cerevisiae, cause less than 10 % of all cases of vulvovaginitis with some regional variation; these are generally associated with milder signs and symptoms than normally seen with a Candida albicans-associated vaginitis.</s><s>Typical symptoms include premenstrual itching, burning, redness and odorless discharge.</s><s>Although itching and redness of the introitus and vagina are typical symptoms, only 35-40 % of women reporting genital itching in fact suffer from vulvovaginal candidosis.</s></p><p><s>Vulvovaginal Candidosis (excluding chronic mucocutaneous candidosis).</s><s>Guideline of the German Society of Gynecology and Obstetrics (AWMF Registry No. 015/072, S2k Level, December 2013) Medical history, clinical examination and microscopic examination of vaginal content using 400 × optical magnification, or preferably phase contrast microscopy, are essential for diagnosis.</s><s>In clinically and microscopically unclear cases and in chronically recurring cases, a fungal culture for pathogen determination should be performed.</s><s>In the event of non-Candida albicans species the minimum inhibitory concentration (MIC) should also be determined.</s><s>Chronic mucocutaneous candidosis, a rarer disorder which can occur in both sexes, has other causes and requires different diagnostic and treatment measures.</s><s>Treatment with all antimycotic agents on the market (polyenes such as nystatin; imidazoles, such as clotrimazole; and many others including ciclopirox olamine) is easy to administer in acute cases and is successful in more than 80% of cases.</s><s>All vaginal preparations of polyenes, imidazoles and ciclopirox olamine and oral triazoles (fluconazole, itraconazole) are equally effective (l " Table <ref type="table" target="#tab_4">4</ref>), however oral triazoles should not be administered during pregnancy according to the manufacturers.</s><s>Candida glabrata is not sufficiently sensitive to the usual dosages of antimycotic agents approved for gynecological use.</s><s>In other countries vaginal suppositories of boric acid (600 mg, 1-2 times daily for 14 days) or flucytosine are recommended.</s><s>Boric acid treatment is not allowed in Germany and flucytosine is not available.</s><s>800 mg oral fluconazole per day for 2-3 weeks is therefore recommended in Germany.</s><s>Due to the clinical persistence of Candida glabrata despite treatment with high-dose fluconazole, oral posaconazole and, more recently, echinocandins such as mica-fungin are under discussion; echinocandins are very expensive, are not approved for this indication and are not supported by clinical evidence of their efficacy.</s><s>In cases of vulvovaginal candidosis, resistance to Candida albicans does not play a significant role in the use of polyenes or azoles.</s><s>Candida krusei is resistant to the triazoles fluconazole and itraconazole.</s><s>For this reason, local imidazole, ciclopirox olamine or nystatin should be used.</s><s>There are no studies to support this recommendation, however.</s><s>Side effects, toxicity, embryotoxicity and allergies are not clinically significant.</s><s>Vaginal treatment with clotrimazole in the first trimester of a pregnancy reduces the rate of premature births.</s><s>Although it is not necessary to treat a vaginal colonization of Candida in healthy women, vaginal administration of antimycotics is often recommended in the third trimester of pregnancy in Germany in order to reduce the rate of oral thrush and diaper dermatitis in healthy full-term newborns.</s><s>Chronic recurrent vulvovaginal candidosis (CRVVC) continues to be treated in intervals using suppressive therapy as long as immunological treatments are not available.</s><s>The relapse rate associated with weekly or monthly oral fluconazole treatment over 6 months is approximately 50 % after the conclusion of suppressive therapy according to current studies.</s><s>Good results have been achieved with a fluconazole regimen using an initial 200 mg fluconazole per day on three days in the first week and a dosage-reduced maintenance therapy with 200 mg once a month for one year when the patient is free of symptoms and fungal infection (l " Fig. <ref type="figure" target="#fig_0">2</ref>).</s><s>Future studies should include Candida autovaccination, antibodies to Vulvovaginal candidosis is an infection of the estrogenized vagina and vestibulum which can also extend to the outer sides of the labia minora, the labia majora, the intercrural region and the perineal region.</s><s>Candidosis of the cervix or endometrium is unknown.</s><s>Connatal fetal candidosis and candidal amnionitis are rare.</s><s>The terms "vulvovaginal candidosis" and "Candida albicans vulvovaginitis" are preferred <ref type="bibr" target="#b99">[99]</ref>.</s><s>The suffix "-iasis" should be reserved for parasitic infections such as trichomoniasis <ref type="bibr" target="#b69">[69]</ref>, but is unfortunately widely used in the Anglo-American literature.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>2</head><p><s>Summary of Recommendations</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">Microbiology</head><p><s>Candida albicans forms in vitro blastospores, germ tubes, pseudomycelia, true mycelia and also chlamydospores on special culture media.</s><s>Candida glabrata appears almost exclusively as a blastospore.</s><s>The formation of pseudohyphae (except Candida glabrata and several other Candida species, which only appear as blastospores) indicates an infection <ref type="bibr" target="#b83">[83,</ref><ref type="bibr" target="#b133">133]</ref>.</s><s>Candida species and strains differ in their pathogenicity (in vitro), so that the development of a candidosis depends on the Candida species and the relative strength or weakness of the hostʼs defense mechanisms <ref type="bibr" target="#b7">[8]</ref>.</s><s>85-95 % of the Candida species colonizing the vagina in premenopausal and pregnant, asymptomatic, healthy women and in women with acute vaginal candidosis are Candida albicans.</s><s>Close relatives are Candida stellatoidea, which seems to be rare in vulvovaginal candidoses (l " Fig. <ref type="figure">1</ref> and Table <ref type="table" target="#tab_2">2</ref>), and Candida africana (l " Table <ref type="table" target="#tab_3">3</ref>).</s><s>Both were only identified by special diagnostic procedures <ref type="bibr" target="#b117">[117,</ref><ref type="bibr" target="#b128">128]</ref>.</s><s>Exact epidemiologic data are missing.</s><s>Non-Candida albicans species, particularly Candida glabrata, are more likely to be identified in postmenopausal, diabetic and immune-suppressed women <ref type="bibr" target="#b23">[23,</ref><ref type="bibr" target="#b52">52,</ref><ref type="bibr" target="#b53">53,</ref><ref type="bibr" target="#b67">67,</ref><ref type="bibr" target="#b81">81,</ref><ref type="bibr" target="#b98">98,</ref><ref type="bibr" target="#b100">100]</ref>.</s><s>There are significant regional differences in the distribution of Candida species (l " Fig. <ref type="figure">1</ref> and Table <ref type="table" target="#tab_2">2</ref> as an example for Berlin) but no evi-dence for the increased occurrence of non-Candida albicans species in vaginal colonization.</s><s>In a retrospective, four-year, PCRbased study of 93 775 cervical-vaginal smears taken for the clarification of vulvovaginal candidosis, C. albicans was found in 89 %, C. glabrata in 7.9 % and other Candida species in less than 2% of samples <ref type="bibr" target="#b147">[147]</ref>; similar incidences were found in German <ref type="bibr" target="#b80">[80,</ref><ref type="bibr" target="#b81">81]</ref> (l " Table <ref type="table" target="#tab_3">3</ref>) and British studies <ref type="bibr" target="#b55">[55]</ref>.</s><s>Candida krusei, Candida guilliermondii, Candida tropicalis, Candida parapsilosis and other species can cause vulvovaginitis with typical symptoms in individual cases <ref type="bibr" target="#b81">[81,</ref><ref type="bibr" target="#b97">97,</ref><ref type="bibr" target="#b129">129,</ref><ref type="bibr" target="#b133">133,</ref><ref type="bibr" target="#b138">138]</ref>.</s><s>Saccharomyces cerevisiae very rarely causes vaginal complaints <ref type="bibr" target="#b83">[83,</ref><ref type="bibr" target="#b131">131]</ref> but has been identified asymptomatically in 1 to 2 % of vaginal cultures <ref type="bibr" target="#b81">[81,</ref><ref type="bibr" target="#b100">100]</ref> (l " Table <ref type="table" target="#tab_3">3</ref>).</s><s>Different genotypes of Candida albicans strains have been identified in asymptomatic women and in those with acute Candida vaginitis <ref type="bibr" target="#b68">[68]</ref>.</s><s>Identical Candida albicans strains could be identified in the oro-intestinal tract and in the vagina of the same woman, as well as the sperm of her asymptomatic partner using PCR <ref type="bibr" target="#b79">[79]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">Virulence Factors of Candida albicans</head><p><s>The first step between colonization and infection is the attachment of the Candida cell to the vaginal wall with the help of mannoproteins <ref type="bibr" target="#b38">[38,</ref><ref type="bibr" target="#b135">135,</ref><ref type="bibr" target="#b142">142]</ref>.</s></p><p><s>The capacity to form pseudohyphae and the secretion of hydrolytic proteins such as secretory aspartate proteinases (Sap 1-10) are probably the most significant virulence factors <ref type="bibr" target="#b6">[7,</ref><ref type="bibr" target="#b92">92,</ref><ref type="bibr" target="#b120">120]</ref>.</s><s>These correlate with pathogenicity <ref type="bibr" target="#b16">[16,</ref><ref type="bibr" target="#b51">51]</ref>.</s></p><p><s>Siderophores enable the use of the hostʼs iron <ref type="bibr" target="#b50">[50,</ref><ref type="bibr" target="#b60">60]</ref>.</s><s>Additional host factors are a strong pH tolerance of 2 to 11 <ref type="bibr" target="#b75">[75]</ref> and enzymes which enable Candida albicans to survive in macrophages <ref type="bibr" target="#b66">[66]</ref>.</s><s>Bacteria and fungi can form biofilms in which they are highly organized in a matrix substance either alone or symbiotically, and protected.</s><s>Auler et al. <ref type="bibr" target="#b3">[4]</ref> and Chassot et al. <ref type="bibr" target="#b21">[21]</ref> describe a biofilm phenomenon involving C. albicans on intrauterine pessaries.</s><s>In systematic examinations of women with vulvovaginal candidosis in Berlin and China using a clear definition of biofilm, non-Candida biofilms were found in numerous vaginal tissue samples; the well-known phenomenon that Candida pseudohyphae penetrate vaginal tissue 8 to 10 cell layers deep <ref type="bibr" target="#b126">[126]</ref> and that numerous other bacteria in abnormal vaginal flora enable penetration was recently demonstrated in vulvovaginal candidosis using fluorescence in situ hybridization (FISH) <ref type="bibr" target="#b139">[139]</ref>.</s><s>Fig. <ref type="figure">1</ref> Candida colonization of the vagina in healthy women <ref type="bibr" target="#b81">[81]</ref>.</s></p><formula xml:id="formula_0">C. dubliniensis 1 1.2 0 - 1 1.9 0 - C. famata 0 - 1 16.7 0 - 0 - C. parapsilosis 1 1.2 0 - 0 - 1 3.3</formula><p><s>The step between colonization and vaginitis is not yet fully understood and highlights the importance of host factors <ref type="bibr" target="#b41">[41]</ref>.</s><s>It can be said attachment to the vaginal epithelium occurs after colonization, and then, with the help of Candida virulence factors, particularly secretory aspartate proteases, invasion, infection and inflammation result.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">Genital Colonization</head><p><s>On account of the estrogenization of the vagina <ref type="bibr" target="#b29">[29]</ref> and the estrogen receptors of Candida albicans <ref type="bibr" target="#b107">[107,</ref><ref type="bibr" target="#b140">140]</ref>, pre-menarchal girls and post-menopausal women are less frequently vaginally colonized and generally do not suffer from Candida vaginitis.</s><s>It has also been confirmed in animal tests that vaginal candidosis can only occur in sterilized animals after the administration of estrogen.</s><s>Healthy, pre-menopausal women who are not pregnant are vaginally colonized in approximately 20 to 30 % of cases, at least 30 % of pregnant women are colonized in the third trimester and at least 30 % of immune-deficient women are found to be colonized to the extent that cultures are used for detection <ref type="bibr" target="#b81">[81,</ref><ref type="bibr" target="#b98">98]</ref> (l " Fig. <ref type="figure">1</ref> and Table <ref type="table" target="#tab_2">2</ref>).</s><s>With PCR, the detection of a vaginal Candida colonization is at least 10 % higher <ref type="bibr" target="#b152">[152]</ref>.</s><s>Vaginal colonization can vary individually from time to time.</s><s>In a longitudinal cohort study with 1248 healthy, asymptomatic young women, 70 % were colonized at least once over the course of one year, although only 4 % were colonized at all visits which took place every three months.</s><s>Recent sexual intercourse, the injection of medroxyprogesterone acetate (an ovulation inhibitor) and simultaneous colonization with lactobacillus and B streptococcus were identified as risk factors <ref type="bibr" target="#b5">[6]</ref>.</s></p><p><s>The partnerʼs sperm can be colonized with the identical Candida strain as in the vagina <ref type="bibr" target="#b79">[79]</ref>, even when the partner is symptomfree.</s><s>Candida balanitis should be treated, although temporary redness of the glans after intercourse with a Candida-colonized woman can also represent an allergic response to Candida antigens.</s><s>It is not clear whether the colonization of the partnerʼs genital tract or the oro-intestinal tract of both partners can play a role in chronic recurring Candida vaginitis <ref type="bibr" target="#b133">[133]</ref>.</s></p><p><s>There is no evidence of an increase in the incidence of either acute or chronic recurring vaginal candidosis in gynecology.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="6">Predisposing Host Factors</head><p><s>Patients with diabetes mellitus suffer from vaginal candidosis more frequently and treatment is likely to fail when serum glucose levels are not normalized <ref type="bibr" target="#b11">[12]</ref>.</s><s>Lower glucose tolerance was also found in approximately 25 % more women with CRVVC than in healthy controls <ref type="bibr" target="#b32">[32]</ref>.</s><s>Obesity, in conjunction with intertrigo caused by rubbing and sweating, can contribute to candidosis in the genital area.</s><s>Although Candida glabrata is less virulent, women with Type II diabetes mellitus are more frequently colonized than healthy women <ref type="bibr" target="#b67">[67,</ref><ref type="bibr" target="#b109">109]</ref>.</s><s>Vaginal Candida colonization is probably not increased by modern oral contraceptives with low estrogen levels <ref type="bibr" target="#b28">[28]</ref>, which do not significantly influence carbohydrate metabolism <ref type="bibr" target="#b48">[48]</ref>.</s><s>This also applies to the frequency of vaginal candidosis <ref type="bibr" target="#b44">[44]</ref>.</s><s>There are some contradictory observations, however <ref type="bibr" target="#b19">[19,</ref><ref type="bibr" target="#b122">122]</ref>.</s><s>In a systematic review of the literature others have observed an increase in vulvovaginal candidosis when oral contraceptives are used, although this depends on the estrogen dosage <ref type="bibr" target="#b153">[153]</ref>.</s></p><p><s>Women with high estrogen levels, and particularly during pregnancy, more regularly experience vaginal Candida colonization.</s><s>Women who are already vaginally colonized by Candida species have an up to 33 % higher risk of developing a vaginal candidosis after treatment with antibiotics <ref type="bibr" target="#b34">[34,</ref><ref type="bibr" target="#b102">102,</ref><ref type="bibr" target="#b104">104,</ref><ref type="bibr" target="#b159">159]</ref>.</s></p><p><s>Although vaginal candidosis often occurs in women with normal lactobacillus flora, lower numbers of lactobacilli have been found in women with vaginal candidosis <ref type="bibr" target="#b2">[3]</ref>.</s><s>It is assumed meanwhile that special strains of lactobacilli (for example Lactobacillus rhamnosus) can play a protective role against vaginal candidosis <ref type="bibr" target="#b71">[71,</ref><ref type="bibr" target="#b72">72]</ref>.</s><s>Sobel <ref type="bibr" target="#b133">[133]</ref> emphasizes the likely underestimated role of sexual activity in the recurrence of vaginal candidosis, as re-infections are frequently observed after sexual intercourse, particularly oro-genital contact <ref type="bibr" target="#b34">[34,</ref><ref type="bibr" target="#b111">111,</ref><ref type="bibr" target="#b122">122]</ref>.</s></p><p><s>Finally, genetic factors are also responsible for recurrences; gene polymorphisms of mannose-binding lectin <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b30">30]</ref> and a non-secretor pheneotype of the ABO-Lewis blood group have been identified as risk factors <ref type="bibr" target="#b20">[20]</ref>.</s></p><p><s>Four female members of a Dutch family were affected either by recurring vulvovaginal candidosis or onychomycosis and displayed a specific mutation (loss of the last 9 amino acids in the carbohydrate recognition domain).</s><s>The modified form of the lectin Dectin-1 caused by this mutation led to insufficient production of cytokines (interleukin-17, tumor necrosis factor, interleukin-6) after stimulation with beta-glucan or Candida albicans.</s><s>In contrast, phagocytosis and elimination of fungi was unaffected in these patients, which explains why a lack of Dectin-1 is not associated with fungal infections.</s><s>Interestingly, symptoms appeared in the homozygotic daughters between 10-12 years of age, while the age of manifestation in the heterozygotic mother and father was between 40 and 55 years; this suggests both hormonal and gene-dosage effects <ref type="bibr" target="#b40">[40]</ref>.</s><s>The documented mutation is notably common in parts of Africa and Europe (3-7%).</s><s>Meanwhile deeper insights have been gained in the complex field of innate and acquired immunity.</s><s>Of interest are the known factors of innate and acquired humoral immunity and the factors which should neutralize Candida in order to prevent the steps between asymptomatic colonization, attachment and infection.</s></p><p><s>Vaginal microbiota also play a not yet sufficiently understood role.</s><s>Th-1-induced dendritic T cells/Langerhans cells are supported by interleukin 12. Oral and vaginal epithelial cells are capable of differentiating the Candida polymorphism (colonizing blastospores or infectious pseudohyphae).</s><s>They then produce proinflammatory cytokines which activate neutrophils.</s><s>These are not protective in the vagina, however, and cause inflammation here instead.</s><s>Recently, the importance of antibodies to parts of Candida was (again) recognized.</s><s>It was found the antibodyproducing B cells have protective effects in vaginal candidosis <ref type="bibr" target="#b18">[18,</ref><ref type="bibr" target="#b58">58,</ref><ref type="bibr" target="#b62">62,</ref><ref type="bibr" target="#b116">116,</ref><ref type="bibr" target="#b146">146]</ref>.</s></p><p><s>Women with an atopic diathesis and type 1 allergies develop vaginal candidosis significantly more often than others <ref type="bibr" target="#b93">[93]</ref>.</s><s>The clinical symptoms of vaginal candidosis, such as redness and itching, are seen as an expression of allergic phenomena, particularly in recurring cases <ref type="bibr" target="#b133">[133,</ref><ref type="bibr" target="#b156">156]</ref>.</s></p><p><s>Women with a history of recurring Candida vaginitis express heat shock proteins during symptom-free intervals, which can provoke similar immunological defense reactions in the same way as Candida cells <ref type="bibr" target="#b49">[49,</ref><ref type="bibr" target="#b110">110]</ref>.</s></p><p><s>Psychosocial stress can also trigger CRVVC, likely due to immune suppression <ref type="bibr" target="#b35">[35,</ref><ref type="bibr" target="#b87">87]</ref>.</s><s>Vice versa, CRVVC has a considerable negative influence on the patientʼs professional and private life <ref type="bibr" target="#b85">[85]</ref>.</s></p><p><s>Because infection requires both colonization and dispositioncandidosis is the infection of the infectedimmune-suppressed individuals are particularly likely to develop candidosis.</s><s>75% of otherwise healthy women develop vulvovaginal candidosis at least once in their lives and many experience more than 4 episodes per year (chronic recurring vulvovaginal candidosis/ CRVVC) <ref type="bibr" target="#b23">[23,</ref><ref type="bibr" target="#b133">133]</ref>.</s><s>In an internet questionnaire with 6000 women in 5 European countries and the USA, 30-50% of women in each country reported having vulvovaginal candidosis at least once, and approximately 9% suffered from CRVVC for several years <ref type="bibr" target="#b45">[45]</ref>.</s><s>Nonetheless, no correlation was found between the frequency of antibiotic prescriptions and chronic recurring vulvovaginal candidosis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="7">Clinical Symptoms</head><p><s>Due to the influence of estrogen, pre-menopausal women normally suffer primarily from vaginal candidosis, which can extend to the vulva, while post-menopausal women typically suffer from vulvar and/or intercrural candidosis.</s><s>Clinical symptoms typically appear prior to menstruation: the cell proliferation induced by estrogens and the cytolysis induced by progesterone releases glycogen, which can be metabolized by lactobacilli, increase glucose levels in the vagina <ref type="bibr" target="#b34">[34]</ref>.</s></p><p><s>In approximately 90 % of patients, itching is the most important, but not the most reliable, symptom, as only 35-40% of the women suffering from itching are found to have vaginal candidosis <ref type="bibr" target="#b1">[2,</ref><ref type="bibr" target="#b81">81,</ref><ref type="bibr" target="#b152">152]</ref>.</s><s>Discharge can range widely from fluid (often at the start of an acute vaginal candidosis) to clumpy, or in CRVVC can be entirely absent <ref type="bibr" target="#b137">[137]</ref>.</s><s>Vulvovaginal candidoses can be divided into simple and complex cases from a clinical and therapeutic standpoint <ref type="bibr" target="#b133">[133]</ref>.</s><s>The pseudohyphae used for differentiation are not always found microscopically in all cases of the so-called simple candidosis.</s></p><p><s>Most patients complain of vaginal redness, soreness, burning, dyspareunia and dysuria.</s><s>These symptoms alone are not sufficient for the clinician to reliably determine the causes of an episode of vaginitis.</s><s>On the other hand, itching and redness are very rarely absent in vaginal candidosis <ref type="bibr" target="#b1">[2]</ref>.</s><s>The discharge does not have an unpleasant odor in contrast to bacterial vaginosis.</s><s>The inner labia can be odematous, and burning fissures are seen particularly in CRVVC.</s><s>From a dermatological standpoint, vulvar candidosis can be divided into vesicular, eczematoid and follicular (hair follicle) forms (after <ref type="bibr" target="#b82">[82]</ref>).</s></p><p><s>In severe cases, a thick layer of discharge can attach to the vaginal wall and lead to minor bleeding when removed.</s><s>Candida glabrata vaginitis is rare and generally occurs in the late pre-pausal and peri-pausal period <ref type="bibr" target="#b42">[42,</ref><ref type="bibr" target="#b55">55,</ref><ref type="bibr" target="#b76">76,</ref><ref type="bibr" target="#b132">132,</ref><ref type="bibr" target="#b138">138]</ref>.</s><s>Candida krusei vaginitis <ref type="bibr" target="#b129">[129]</ref>, Candida parapsilosis vaginitis <ref type="bibr" target="#b97">[97]</ref> and the rare Saccharomyces cerevisiae vaginitis <ref type="bibr" target="#b83">[83,</ref><ref type="bibr" target="#b123">123,</ref><ref type="bibr" target="#b131">131]</ref> are generally similar to Candida glabrata vaginitis and are associated with only mild clinical symptoms.</s><s>Candida cervicitis is unknown.</s></p><p><s>In comparison to the general population and using established evaluation criteria, women with CRVVC are significantly impacted in their quality of life and health status in a manner comparable to asthma or chronic obstructive bronchitis and show sig-nificantly reduced productivity in their professional and daily lives <ref type="bibr" target="#b0">[1]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8">Diagnosis</head><p><s>The diagnosis of vaginal candidosis is always made using a combination of medical history, clinical symptoms and the detection of yeasts.</s><s>Clinical diagnosis can be difficult, as a vulvovaginal candidosis is not necessarily present even when Candida has been detected and itching of the introitus occurs.</s><s>In a prospective study of the accuracy of clinical diagnosis of bacterial vaginosis, trichomoniasis and vulvovaginal candidosis in 535 soldiers with vulvovaginal complaints, the sensitivity and specificity of the diagnosis using classical diagnostic methods (medical history, vaginal examination, pH-value, microscopy of native preparation) amounted to 83.8-84.8</s><s>% <ref type="bibr" target="#b70">[70]</ref>; which corresponded with the earlier results of Müller et al. <ref type="bibr" target="#b90">[90]</ref>, whereas Candida could be identified in 20.9 % using PCR in contrast to 14 % of all women.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.1">Necessary diagnostics</head><p><s>Medical history, gynecological examination and microscopic examination of discharge using a saline solution or 10% potassium hydroxide solution under 400 × optical magnification, or preferably phase contrast microscopy, are essential for diagnosis <ref type="bibr" target="#b83">[83,</ref><ref type="bibr" target="#b91">91]</ref>.</s><s>pH measurement can also be performed if necessary.</s><s>Blastospores or (pseudo-)hyphae can be found microscopically in approximately 50 to 80 % of vaginal candidosis cases <ref type="bibr" target="#b90">[90,</ref><ref type="bibr" target="#b133">133]</ref>, although they are only microscopically visible during colonization in approximately half of the cases.</s><s>An increased number of leucocytes may be found in discharge, but this is not necessarily always the case.</s><s>In the event that no blastospores or (pseudo-)hyphae can be found during microscopy or if the case is a CRVVC or is otherwise complicated, it is necessary to perform a culture in order to determine the species involved <ref type="bibr" target="#b34">[34,</ref><ref type="bibr" target="#b57">57,</ref><ref type="bibr" target="#b96">96]</ref>.</s><s>Sabouraud glucose agar is the typical medium for performing diagnostic cultures.</s><s>Other equally sensitive and reliable media are also available, including chrome agar for differentiation and Microstix-Candida.</s><s>It is possible that two or more different yeast species can be cultured in a case of vaginal candidosis, for example Candida albicans and Candida glabrata.</s><s>The patient typically suffers from a Candida albicans vaginitis while the generally resistant Candida glabrata remains in situ after treatment.</s><s>It is generally only present as a colonization and need not be treated again in the absence of symptoms.</s></p><p><s>In vitro sensitivity testing is not necessary and at most only if non-Candida albicans species are found and the infection chronically recurs.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="8.2">Unnecessary diagnostics</head><p><s>Serological tests are not considered useful for the diagnosis of vulvovaginal candidosis because low levels of antibodies can be found in most peopleʼs blood.</s><s>Antibodies are measurable in women both with and without vaginal candidosis (for example due to intestinal colonization).</s><s>Superficial vaginal candidosis does not cause increased antibody levels.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Treatment</head><p><s>There are a great number of options for conventional and alternative treatments <ref type="bibr" target="#b154">[154]</ref>.</s><s>Polyenes form complexes using the ergosterol of the yeast membranes and alter their permeability <ref type="bibr" target="#b124">[124]</ref>.</s><s>Azoles hinder the conversion of lanosterol to ergosterol in the yeast cell membranes <ref type="bibr" target="#b106">[106]</ref>.</s><s>Ciclopirox olamine hinders important iron-dependent enzymes through the formation of chelate <ref type="bibr" target="#b94">[94]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.1">Colonization</head><p><s>Even with high bacteria counts, asymptomatic vaginal colonization does not require treatment provided that the patient is immunocompetent and does not suffer from CRVVC.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.2">Colonization during pregnancy</head><p><s>Almost all healthy full-term newborns who are colonized with Candida albicans during vaginal birth will develop oral thrush and/or diaper dermatitis at some point in the first year of life, peaking in the 2nd to 4th weeks <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b10">11]</ref>.</s><s>For this reason, prophylactic treatment of asymptomatic Candida colonization is recommended in Germany in the final weeks of pregnancy in order to prevent the colonization and subsequent infection of the newborn during vaginal birth.</s><s>This significantly reduces the occurrence of oral thrush and diaper dermatitis from approximately 10 to 2% in the fourth week of life <ref type="bibr" target="#b9">[10,</ref><ref type="bibr" target="#b84">84,</ref><ref type="bibr" target="#b125">125]</ref>.</s></p><p><s>In retrospective studies <ref type="bibr" target="#b24">[24]</ref><ref type="bibr" target="#b25">[25]</ref><ref type="bibr" target="#b26">[26]</ref><ref type="bibr" target="#b54">54]</ref> and one prospective study <ref type="bibr" target="#b63">[63]</ref> a significant reduction in premature births was found after vaginal treatment with clotrimazole in the first trimester of pregnancy.</s><s>In an Australian study with a relatively small number of patients, only a non-significant reduction in premature births was observed after clotrimazole treatment in the first trimester <ref type="bibr" target="#b115">[115]</ref>.</s><s>It is under discussion whether non-Candida albicans species, inflammatory cytokines triggered by Candida in the vagina, or the antibacterial components of clotrimazole play the decisive role against gram-positive coccoids.</s><s>More prospective studies are therefore needed.</s></p><p><s>Since the introduction of triazoles around 1990 no neonatal deformities have been observed in the first trimester <ref type="bibr" target="#b24">[24,</ref><ref type="bibr" target="#b73">73]</ref>.</s><s>According to a Danish study, the administration of fluconazole in typical gynecological dosages of 150-300 mg/day is harmless throughout pregnancy.</s><s>In a cohort of 7352 pregnancies, however, 7 incidences of Fallot tetralogy were found in association with the medically indicated cumulative administration of 150-6000 mg of flucanozole in the first trimester; in the control group of 968 236 pregnancies where no flucanozole was administered in the first trimester, a significantly lower incidence was reported <ref type="bibr" target="#b88">[88]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.3">Treatment of acute vulvovaginal candidosis</head><p><s>Acute vulvovaginal candidosis can be treated locally with polyenes (nystatin, amphotericin B), imidazoles (clotrimazole, miconazole nitrate, econazole nitrate, fenticonazole nitrate) <ref type="bibr" target="#b77">[77,</ref><ref type="bibr" target="#b133">133]</ref> or ciclopirox olamine <ref type="bibr" target="#b148">[148]</ref> (l " Table <ref type="table" target="#tab_4">4</ref>).</s></p><p><s>Vaginal suppositories and creams are available with dosages and preparations for treatment periods ranging from 1 to 3 days and 6 or 7 days and are considered harmless for patients <ref type="bibr" target="#b114">[114]</ref>.</s></p><p><s>Oral treatment with the triazoles fluconazole and itraconazole are also possible.</s><s>The mycological and clinical success rates for the different approved treatment regimens are basically the same outside pregnancy and range from approximately 85% at one to two weeks and 75 % at 4 to 6 weeks after treatment <ref type="bibr" target="#b22">[22,</ref><ref type="bibr" target="#b80">80,</ref><ref type="bibr" target="#b95">95,</ref><ref type="bibr" target="#b105">105,</ref><ref type="bibr" target="#b134">134</ref>].</s></p><p><s>Treatment success rates during pregnancy are significantly better with imidazoles than with polyenes <ref type="bibr" target="#b160">[160]</ref>.</s></p><p><s>In the event that the candidosis extends to the vulvar region outside the vaginal introitus or to the inguinal region, an antimycotic skin cream, for example clotrimazole, is recommended 2 × daily for approximately one week.</s><s>The combination of intravaginal treatment of acute vulvovaginal candidosis with additional cream for the vulva appears to produce better treatment results than intravaginal treatment alone.</s><s>There are few studies available to support this, however <ref type="bibr" target="#b86">[86,</ref><ref type="bibr" target="#b108">108]</ref>.</s></p><p><s>"Blind" treatment of the asymptomatic sexual partner is not beneficial for the patient <ref type="bibr" target="#b8">[9,</ref><ref type="bibr" target="#b14">14,</ref><ref type="bibr" target="#b133">133]</ref>.</s><s>No studies have been found which demonstrate a benefit for the patient from treating the asymptomatic sexual partner who is colonized on the penis or in the sperm.</s></p><p><s>Vaginal candidosis occurs much more frequently in HIV-positive women (l " Fig. <ref type="figure">1</ref>).</s><s>This problem and the multiple issues involved in treatment are examined in the HIV guidelines regarding the treatment of opportunistic infections <ref type="bibr" target="#b141">[141]</ref>.</s><s>Sexual partners of HIV-positive women should be informed of the increased risk of infection if they display a predisposition to Candida balanitis.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.4">Side effects</head><p><s>All vaginal and local antimycotics are well tolerated.</s><s>Azoles and ciclopirox olamine can cause minor local burning in 1 to 10 % of cases <ref type="bibr" target="#b77">[77,</ref><ref type="bibr" target="#b80">80]</ref>.</s><s>Allergic reactions are possible but rare.</s><s>Hydrophilic fluconazole and lipophilic itraconazole rarely cause side effects in normal dosages.</s><s>Itraconazole causes significantly more side effects during systemic treatment than fluconazole (for example anaphylactic reactions, headaches, etc.).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.5">Resistence to Candida albicans?</head><p><s>Although strains of vaginal Candida albicans have been found with higher minimal inhibitory concentrations against fluconazole <ref type="bibr" target="#b112">[112]</ref>, cases of azole resistance in vaginal candidosis are rare <ref type="bibr" target="#b74">[74,</ref><ref type="bibr" target="#b112">112]</ref>.</s><s>Clinical resistance does not correlate with minimal inhibitory concentrations and vice versa.</s><s>For this reason resistance tests are generally not recommended <ref type="bibr" target="#b133">[133]</ref>, unless the case involves non-Candida albicans species.</s><s>Sensitivity testing should " Vaginal cream 10 mg/g: 50 mg daily for 6 days be performed in a laboratory experienced in mycology when a Candida albicans vulvovaginitis reappears after a longer period of chemoprophylaxis using fluconazole <ref type="bibr" target="#b127">[127]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.6">Non-Candida albicans vaginitis</head><p><s>Typical vaginal and oral treatments are generally unsuccessful against Candida glabrata vaginitis.</s><s>Sobel et al. <ref type="bibr" target="#b136">[136]</ref> therefore recommend vaginal suppositories containing 600 mg boric acid for 14 days, while Philips <ref type="bibr" target="#b101">[101]</ref> recommends amphotericin B. In treatment resistant cases, vaginal treatment for two weeks using 17 % flucytosine is successful in 90% of cases <ref type="bibr" target="#b136">[136]</ref>.</s><s>Boric acid treatment is not permitted in Germany and vaginal flucytosine preparations are not available.</s><s>It was therefore recommended until recently that 800 mg fluconazole be administered orally for 2 to 3 weeks against Candida glabrata vaginitis (but not colonization!)</s><s><ref type="bibr" target="#b65">[65,</ref><ref type="bibr" target="#b82">82]</ref>.</s><s>Even with this treatment, failures have increasingly been seen.</s><s>For this reason Tietz <ref type="bibr" target="#b143">[143]</ref> recommended the oral administration of posaconazole together with local treatment with ciclopirox olamine and/or nystatin for 15 days on the basis of remission in 14 of 15 patients.</s><s>He did begin to observe quickly emerging resistance as well as treatment failure with that regimen, however.</s><s>He then described the successful treatment of 14 patients with C. glabrata infections of the vagina at several German universities and his own institute using micafungin, an echinochandin approved for the treatment of life-threatening mycoses, for example in hematooncology <ref type="bibr" target="#b144">[144]</ref>.</s><s>Such measures are only appropriate in exceptional cases involving significant illness as this is an "off-label", non-approved use.</s><s>Candida krusei vaginitis is resistent to fluconazole and flucytosin, however local clotrimazole, ciclopirox olamine <ref type="bibr" target="#b83">[83,</ref><ref type="bibr" target="#b144">144]</ref> and (for example, in the USA) boric acid <ref type="bibr" target="#b129">[129]</ref> can be used.</s><s>Nystatin treatment is also prone to failure.</s><s>Due to the rareness of such cases, no results are available from clinical studies.</s><s>There are also no studies available which compare antimycotics and antiseptics.</s><s>Dequalinium chloride is effective in vitro <ref type="bibr" target="#b15">[15]</ref>, while octenidine and others have at least been tested as alternatives for acute vulvovaginal candidosis <ref type="bibr" target="#b46">[46,</ref><ref type="bibr" target="#b47">47]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="9.7">Chronically recurring Candida albicans vulvovaginitis</head><p><s>Because infection requires colonization and disposition and treatment of the underlying disposition (local weakness of the immune system) has not yet been attempted, local and oral maintenance treatments are recommended for the prevention of recurrences <ref type="bibr" target="#b27">[27,</ref><ref type="bibr" target="#b119">119,</ref><ref type="bibr" target="#b130">130,</ref><ref type="bibr" target="#b134">134]</ref>.</s><s>The results are comparable whether local clotrimazole 500 mg, oral ketoconazole 100 mg or oral fluconazole 150 mg are administered, however recurrence occurs in approximately half of all patients shortly after ending treatment <ref type="bibr" target="#b130">[130,</ref><ref type="bibr" target="#b134">134]</ref>.</s><s>In a placebo-controlled study with a randomized collective of 387 women who received 150 mg fluconazole weekly for 6 months, the group of illness-free women after 12 months totaled 42.9 % in the fluconazole group and 21.9 % in the placebo group <ref type="bibr" target="#b134">[134]</ref>.</s><s>CRVVC is therefore comparable to a chronic, incurable disease <ref type="bibr" target="#b33">[33]</ref>.</s></p><p><s>The treatment and prophylaxis recommended by Donders et al. <ref type="bibr" target="#b31">[31]</ref>, which involves an initial dose of 3 × 200 mg fluconazole in the first week, followed by a dosage-reduced maintenance regimen (l " Fig. <ref type="figure" target="#fig_0">2</ref>), is beneficial as almost 90 % of the patients were found to be illness-free after 6 months and 77 % of the patients remained so at one year.</s><s>The cumulative total dose amounted to 3800 mg fluconazole in 6 months and 5000 mg in one year according to Dondersʼ treatment schedule.</s><s>The administration of 150 mg fluconazole per week amounts to 3600 mg after 6 months, but 7200 mg fluconazole at one year with the same treatment results.</s><s>Removal of intrauterine pessaries should be considered in women with recurring vulvovaginal candidosis because histology and culturing have shown that Candida albicans is significantly more likely to attach to plastic pessaries containing levonorgestrel in women with candidosis than in women without recurrences.</s><s>After removal of the IUD and treatment with fluconazole, these women did not experience recurrences for a long period of time <ref type="bibr" target="#b161">[161]</ref>.</s><s>better immunological responses than commercial Candida antigens <ref type="bibr" target="#b64">[64]</ref>.</s><s>Rigg et al. <ref type="bibr" target="#b113">[113]</ref> reported a Candida allergen treatment, while Moraes et al. <ref type="bibr" target="#b89">[89]</ref> and Rusch and Schwiertz <ref type="bibr" target="#b121">[121]</ref> reported results from a Candida autovaccination, which only used allergoid components as used in hyposensitization.</s><s>There has yet to be a therapeutic breakthrough in this field, despite numerous experiments to better understand the immunopathogenicity of Candida vaginitis <ref type="bibr" target="#b4">[5,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b17">17,</ref><ref type="bibr" target="#b41">41,</ref><ref type="bibr" target="#b59">59,</ref><ref type="bibr" target="#b78">78,</ref><ref type="bibr" target="#b93">93,</ref><ref type="bibr" target="#b151">151,</ref><ref type="bibr" target="#b155">155,</ref><ref type="bibr" target="#b156">156,</ref><ref type="bibr" target="#b158">158]</ref>.</s><s>Intramuscular injection of non-H 2 O 2 -forming "aberrant" lactobacilli, which induce antibody formation and unspecific immune reactions and can be successfully used primarily against trichomoniasis and bacterial vaginosis, failed to reduce the number of recurrences of chronic recurring vulvovaginal candidosis although it did lead to significant improvement in individual scoring in regard to physical and psychological well-being <ref type="bibr" target="#b85">[85]</ref>.</s><s>Alongside a number of methods for inducing the production of antibodies against systemic candidosis, two vaccinations against oral and vulvovaginal candidosis have moved closer to clinical trial: one targets secretory aspartate protease 2 (Sap 2), the most important virulence factor of Candida albicans, while the other targets the agglutinin-like sequence 3 protein Als3p, a cell wall antigen found on the surface of Candida.</s><s>Both led to good antibody formation in animal tests as well as initial human studies, raising hopes for clinical efficacy in a manner similar to boostering <ref type="bibr" target="#b18">[18,</ref><ref type="bibr" target="#b146">146]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="10.2">The significance of lactobacilli</head><p><s>The oral administration of probiotics containing specific lactobacillus strains <ref type="bibr" target="#b36">[36,</ref><ref type="bibr" target="#b56">56,</ref><ref type="bibr" target="#b61">61,</ref><ref type="bibr" target="#b103">103]</ref> have produced encouraging, yet controversial, results which require further investigation.</s><s>Lactobacillus strains have been identified which have fungicidal and immune-stimulating effects in vitro <ref type="bibr" target="#b71">[71]</ref> and have been found to significantly reduce vaginal colonization in vivo after treatment of vulvovaginal candidosis in comparison to placebo <ref type="bibr" target="#b72">[72]</ref>.</s><s>Over a period of six months, monthly administration of lactobacilli for six days in conjunction with itraconazole 2 × 200 mg for one day showed no improvement over itraconazole alone in the reduction of recurrence rates in chronic recurring vulvovaginal candidosis.</s><s>Nonetheless, these treatment measures were found better than classical homeopathy with a high degree of significance <ref type="bibr" target="#b157">[157]</ref>.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>10.3</head><p><s>Over-the-counter treatment?</s></p><p><s>Self-treatment ("over-the-counter" = OTC) of vulvovaginal candidosis using clotrimazole, and also fluconazole in several countries, is practiced meanwhile in more than 80 % of cases.</s><s>Although it was optimistically thought in the early 1990s that patients were almost always able to correctly diagnose vaginal candidosis themselves, this has meanwhile been proven to be incorrect (at least for now) <ref type="bibr" target="#b5">[6,</ref><ref type="bibr" target="#b57">57,</ref><ref type="bibr" target="#b149">149]</ref>.</s><s>Only one third of 95 women who purchased a vaginal antimycotic for self-treatment were found to have a Candida vaginitis <ref type="bibr" target="#b39">[39]</ref>.</s><s>It is therefore being recommended again that treatment should only take place after a correct medical diagnosis has been made.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig. 2</head><label>2</label><figDesc><div><p><s>Fig. 2 Individualized, dose-reduced maintenance treatment with fluconazole in chronically recurring vulvovaginal candidosis (Donders et al. [31].</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table 1</head><label>1</label><figDesc><div><p><s>Authors.</s><s>DGGG Consortium (AG)/AWMF/non-AWMF Professional Societies/Organisation/Association Gynecologists Prof. Dr. Werner Mendling (responsible, leading) German Society for Gynecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe DGGG) Working Group on Infections and Immunology in Gynecology and Obstetrics (Arbeitsgemeinschaft für Infektionen und Infektionsimmunologie in der Gynäkologie und Geburtshilfe AGII) German Mycological Society (Deutschsprachige Mykologische Gesellschaft DMyKG) Prof. Dr. Klaus Friese German Society for Gynecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe DGGG) Working Group on Infections and Immunology in Gynecology and Obstetrics (Arbeitsgemeinschaft für Infektionen und Infektionsimmunologie in der Gynäkologie und Geburtshilfe AGII) Prof. Dr. Ioannis Mylonas German Society for Gynecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe DGGG) Working Group on Infections and Immunology in Gynecology and Obstetrics (Arbeitsgemeinschaft für Infektionen und Infektionsimmunologie in der Gynäkologie und Geburtshilfe AGII) Prof. Dr. Ernst-Rainer Weissenbacher German Society for Gynecology and Obstetrics (Deutsche Gesellschaft für Gynäkologie und Geburtshilfe DGGG) Working Group on Infections and Immunology in Gynecology and Obstetrics (Arbeitsgemeinschaft für Infektionen und Infektionsimmunologie in der Gynäkologie und Geburtshilfe AGII) Dermatologists Introduction</s></p></div></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head>Table 2</head><label>2</label><figDesc><div><p><s>[81]ribution of vaginal Candida species in HIV-negative colonized women[81].</s></p></div></figDesc><table><row><cell>Patients</cell><cell cols="2">premenopausal</cell><cell cols="2">postmenopausal</cell><cell>pregnant</cell><cell></cell><cell>not pregnant</cell><cell></cell></row><row><cell>All</cell><cell>n = 338</cell><cell></cell><cell>n = 45</cell><cell></cell><cell>n = 192</cell><cell></cell><cell>n = 146</cell><cell></cell></row><row><cell>With positive culture</cell><cell>n = 92 (23.3%)</cell><cell></cell><cell>n = 6 (13.3 %)</cell><cell></cell><cell>n = 52 (27.1 %)</cell><cell></cell><cell>n = 30 (20.5%)</cell><cell></cell></row><row><cell></cell><cell>p = 0.003</cell><cell></cell><cell></cell><cell></cell><cell>p = 0.02</cell><cell></cell><cell></cell><cell></cell></row><row><cell></cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell><cell>n</cell><cell>%</cell></row><row><cell>C. albicans</cell><cell>75</cell><cell>91.5</cell><cell>2</cell><cell>33.3</cell><cell>48</cell><cell>92.3</cell><cell>27</cell><cell>90.0</cell></row><row><cell>C. glabrata</cell><cell>4</cell><cell>4.9</cell><cell>2</cell><cell>33.3</cell><cell>2</cell><cell>3.8</cell><cell>2</cell><cell>6.7</cell></row><row><cell>C. krusei</cell><cell>1</cell><cell>1.2</cell><cell>1</cell><cell>16.7</cell><cell>1</cell><cell>1.9</cell><cell>0</cell><cell>-</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_3"><head>Table 3</head><label>3</label><figDesc><div><p><s>[80]ribution of Candida species in 472 cases of acute vaginal candidosis in Poland and Germany[80].</s></p></div></figDesc><table><row><cell></cell><cell>n</cell><cell>%</cell></row><row><cell>Acute Candida vulvovaginitis</cell><cell>472</cell><cell>100</cell></row><row><cell>C. albicans</cell><cell>450</cell><cell>95.3</cell></row><row><cell>C. glabrata</cell><cell>10</cell><cell>2.1</cell></row><row><cell>C. krusei</cell><cell>4</cell><cell>0.9</cell></row><row><cell>Other (C. tropicalis, C. kefyr, C. africana, S. cerevisiae)</cell><cell>11</cell><cell>2.3</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_4"><head>Table 4</head><label>4</label><figDesc><div><p><s>Antimycotic agents against vulvovaginal candidosis.</s><s>Polyenes (since ca.</s><s>1960): " Nystatin: vaginal tablets or vaginal suppositories 100 000 IE, 200 000 IE for 6-day treatment, nystatin cream, nystatin ointment " Amphotericin B (no longer available in Germany for vaginal treatment) Imidazoles (since ca.</s><s>1970): " Clotrimazole, miconazole nitrate, econazole nitrate, fenticonazole nitrate and others in the form of vaginal tablets, vaginal suppositories, vaginal creams, skin creams (for the vulva and perineal areas).</s></p></div></figDesc><table><row><cell>For example,</cell></row></table></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_6"><head></head><label></label><figDesc><div><p><s>[139]r of gaps remain in our knowledge of Candida-host interactions and require further research.For example: How can Candida albicans virulence factors be counteracted?How can the attachment of Candida cells to the vaginal epithelium be reduced?How can the defense mechanisms of the vagina be strengthened (for example T lymphocyte stimulation, humoral factors, allergies)?Is it possible to vaccinate against Candida?Which new antimycotics are able to effectively treat Candida glabrata and Candida krusei intravaginally?How does Candida interact with vaginal flora, as it has been shown that abnormal bacterial flora of the vagina can penetrate the vaginal epithelium together with pseudohyphae, which is not normally the case in bacterial disorders of the vagina[139].</s><s>Why does clotrimazole treatment in early pregnancy reduce the number of premature births?</s><s>Affiliations 1 Deutsches Zentrum für Infektionen in Gynäkologie und Geburtshilfe, Wuppertal 2 Klinikum der Universität München, Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe, München 3 Premium Medizin, München 4 Universitätsklinikum Kiel, Klinik für Dermatologie, Kiel 5 Universitäts-Hautklinik Tübingen, Tübingen 6 Universitätsklinikum Giessen, Klinik für Dermatologie, Venerologie und Allergologie, Giessen 7 Klinikum Bielefeld, Hautklinik, Bielefeld 8 Universitätsklinik für Dermatologie und Venerologie Graz, Graz, Österreich 9 Labor Limbach, Heidelberg 10 Uniklinik Köln, Klinik I für Innere Medizin, Köln 11 Medizinische Klinik mit Schwerpunkt Onkologie und Hämatologie, Charité, Berlin</s></p></div></figDesc><table><row><cell>11</cell><cell>Future Research</cell></row></table><note><p><s>A</s></p></note></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">Mendling W et al. Vulvovaginal Candidosis (excluding … Geburtsh Frauenheilk 2015; 75: 342-354</note>
		</body>
		<back>
			<div type="annex">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Annex Guideline Report</head><note type="other">1</note><p><s>Consensus procedure</s></p><p><s>The guideline was developed in participation with a representative group of professional users.</s><s>Because it represents an update with relatively limited changes, a consensus meeting was not held.</s><s>The changes were gathered using a written DELPHI-procedure, summarized by the coordinator and then inserted.</s><s>In a total of three rounds, this final version was unanimously adopted.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">Patient participation</head><p><s>Patient representatives were not involved due to the lack of appropriate patient organizations.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="4">Participation of professional societies/approval</head><p><s>This guideline was approved by the following professional societies and contributors: " German Society for Gynecology and Obstetrics (DGGG -Deutsche Gesellschaft für Gynäkologie und Geburtshilfe) " Working Group on Infections and Immuology in Gynecology and Obstetrics (AGII -Arbeitsgemeinschaft für Infektionen und Infektionsimmunologie in der Gynäkologie und Geburtshilfe)</s></p><p><s>" German Dermatological Society (DDG -Deutsche Dermatologische Gesellschaft) " German Mycological Society (DmykG -Deutschsprachige Mykologische Gesellschaft)</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">Validity/Updates</head><p><s>The validity of these guidelines was confirmed by the Executive Board of the DGGG and the DGGG Guidelines Commission in December 2013.</s><s>This guideline is valid until 12/2016.</s><s>If potentially relevant changes should occur in the meantime, these will be communicated to the working group by the coordinator and it will be decided whether a revision or addendum is necessary.</s><s>Comments on the guideline are welcome.</s><s>Guideline Coordinator: Prof. W. Mendling.</s></p><p><s>The "guidelines" of the Scientific Medical Professional Societies (Wissenschaftliche Medizinische Fachgesellschaften) are systematically developed aids for the physician in decision-making for specific situations.</s><s>They are based on current scientific knowledge and practically established procedures and thus serve to provide more safety in medicine while also taking economic aspects into consideration.</s><s>The "guidelines" are not legally binding for physicians and thus provide neither a basis for liability claims nor for a freedom from liability.</s><s>The AWMF compiles and publishes the guidelines of the professional societies with the greatest possible careeven so the AWMF cannot accept any responsibility for the correctness of the contents.</s></p><p><s>Especially in the case of dosages, the details provided by the respective manufacturer should always be consulted!</s></p></div>			</div>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Subjective health status and health-related quality of life among women with Recurrent Vulvovaginal Candidosis (RVVC) in Europe and the USA</title>
		<author>
			<persName><forename type="first">S</forename><surname>Aballéa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Guelfucci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wagner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Health Qual Life Outcomes</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="169" to="173" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Evaluation of vaginal complaints</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">R</forename><surname>Anderson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klink</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cohrssen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="1368" to="1379" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Microbial flora associated with candida albicans vulvovaginitis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Auger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Joly</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="397" to="401" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Biofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Auler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Morreiva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">F</forename><surname>Rodriguez</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Mycol</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="211" to="216" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Frequency of interlenkin-4 (IL-4)-589 gene polymorphism and vaginal concentrations of IL-4, nitric oxide, and mannosebinding lectin in women with recurrent vulvovaginal candidiasis</title>
		<author>
			<persName><forename type="first">O</forename><surname>Babula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Lazdane</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kroica</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="1258" to="1262" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Vaginal yeast colonization in nonpregnant women: a longitudinal study</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Beigi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">A</forename><surname>Meyn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Moore</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="926" to="930" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Evidence for a role for secretory asparatate proteinase of Candida albicans in vulvovaginal candidosis</title>
		<author>
			<persName><forename type="first">F</forename><surname>De Bernardis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Agatensi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">K</forename><surname>Ross</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">161</biblScope>
			<biblScope unit="page" from="1276" to="1283" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<monogr>
		<title level="m" type="main">The Role of Immunity against vaginal Candida Infection</title>
		<author>
			<persName><forename type="first">F</forename><surname>De Bernardis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Boccanera</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Cassone</surname></persName>
		</author>
		<editor>Fidel PL, Huffnagle GB</editor>
		<imprint>
			<date type="published" when="2005">2005</date>
			<publisher>Springer</publisher>
			<biblScope unit="page" from="345" to="355" />
			<pubPlace>Heidelberg, New York</pubPlace>
		</imprint>
	</monogr>
	<note>Fungal Immunity: from an Organ Perspective</note>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Co-treatment of the male partner in vaginal candidosis: a double-blind randomized control study</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P</forename><surname>Bisschop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Merkus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Scheygrond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Obstet Gynaecol</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="79" to="81" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Übertragung von Candida und ihre Konsequenzen. Vertical transmission of candida and its consequences</title>
		<author>
			<persName><forename type="first">R</forename><surname>Blaschke-Hellmessen</surname></persName>
		</author>
		<author>
			<persName><surname>Subpartale</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="31" to="36" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>Suppl. 2</note>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Epidemiologische Untersuchungen zum Vorkommen von Hefepilzen bei Kindern und deren Müttern</title>
		<author>
			<persName><forename type="first">R</forename><surname>Blaschke-Hellmessen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mykosen</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="611" to="616" />
			<date type="published" when="1968">1968</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Treatment of vulvovaginal candidiasis in patients with diabetes</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Bohanna</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="451" to="456" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Watson</surname></persName>
		</author>
		<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Grampian Evidence Based Community Pharmacy Guidelines Group. The development of evidence-based guidelines for over-the-counter treatment of vulvovaginal candidiasis</title>
	</analytic>
	<monogr>
		<title level="j">Pharm World Sci</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="177" to="181" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Treatment of vaginal candidosis with natamycin and effect of treating the partner at the same time</title>
		<author>
			<persName><forename type="first">A</forename><surname>Buch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Skytte</forename><surname>Christensen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Obstet Gynecol Scand</title>
		<imprint>
			<biblScope unit="volume">61</biblScope>
			<biblScope unit="page" from="393" to="396" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">Antimicrobial activity of dequalinium chloride against leading germs of vaginal infections</title>
		<author>
			<persName><forename type="first">V</forename><surname>Della Casa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Noll</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Gonser</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arzneimittelforsch</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="699" to="705" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Evidence for a correlation between proteinase secretion and vulvovaginal candidosis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cassone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Bernardis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Mondell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Inf Dis</title>
		<imprint>
			<biblScope unit="volume">156</biblScope>
			<biblScope unit="page" from="777" to="782" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">An outline of the role of anti-candida antibodies within the context of passive immunization and protection from candidiasis</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cassone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>De Bernardis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Torososantucci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Mol Med</title>
		<imprint>
			<biblScope unit="volume">5</biblScope>
			<biblScope unit="page" from="377" to="382" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Recent progress in vaccines against fungal diseases</title>
		<author>
			<persName><forename type="first">A</forename><surname>Cassone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Casadevall</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Microbiol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="427" to="433" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">Distribution of Candida species in women with vulvovaginal symptoms and their association with different ages and contraceptive methods</title>
		<author>
			<persName><forename type="first">M</forename><surname>Cetin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ocak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gungoren</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Scand J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="584" to="588" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Association of recurrent vaginal candidiasis and secretory ABO and Lewis phenotype</title>
		<author>
			<persName><forename type="first">W</forename><surname>Chaim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Foxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="828" to="830" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Can intrauterine contraceptive devices be a Candida albicans reservoir?</title>
		<author>
			<persName><forename type="first">F</forename><surname>Chassot</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">F</forename><surname>Negri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Swidsinski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Contraception</title>
		<imprint>
			<biblScope unit="volume">77</biblScope>
			<biblScope unit="page" from="355" to="359" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Is more than one application of an antifungal necessary in the treatment of an acute vaginal candidosis?</title>
		<author>
			<persName><forename type="first">L</forename><surname>Cohen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">152</biblScope>
			<biblScope unit="page" from="961" to="964" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">An epidemiological survey of vulvovaginal candidiasis in Italy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Corsello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Spinillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Osnengo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Obstet Gynecol Reprod Biol</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="66" to="72" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">No teratogenic effect after clotrimazole therapy during pregnancy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Czeizel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Tóth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Rockenbauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Epidemiology</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="437" to="440" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Preterm birth reduction after clotrimazole treatment during pregnancy</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Czeizel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fladung</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Varga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Obstet Gynecol Reprod Biol</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="157" to="163" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">The use of data set of the Hungarian casecontrol surveillance of congenital abnormalities for evaluation of birth outcomes beyond birth defects</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Czeizel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">H</forename><surname>Puhó</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Kazy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Centr Eur J Public Health</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="147" to="153" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Recurrent vaginal candidosis in women and the effect of intermittent prophylactic treatment</title>
		<author>
			<persName><forename type="first">F</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">F</forename><surname>Mould</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJ Vener Dis</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="176" to="183" />
			<date type="published" when="1978">1978</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">The pill does not cause &apos;thrush&apos;</title>
		<author>
			<persName><forename type="first">F</forename><surname>Davidson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">K</forename><surname>Oates</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Br J Obstet Gynaecol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="1265" to="1266" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">J</forename><surname>Dennerstein</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Ellis</surname></persName>
		</author>
		<author>
			<persName><surname>Oestrogen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Aust N Z J Obstet Gynaecol</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="326" to="328" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Mannose-binding lectin gene polymorphism and resistance to therapy in women with recurrent vulvovaginal candidiasis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Donders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Babula</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bellen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJOG</title>
		<imprint>
			<biblScope unit="volume">115</biblScope>
			<biblScope unit="page" from="1223" to="1231" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Individualized decreasing dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial)</title>
		<author>
			<persName><forename type="first">G</forename><surname>Donders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bellen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Byttebier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">199</biblScope>
			<biblScope unit="page" from="613" to="e614" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
	<note>e9</note>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">Impaired tolerance for glucose in women with recurrent vaginal candidiasis</title>
		<author>
			<persName><forename type="first">G</forename><surname>Donders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Prenen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Verbeke</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">187</biblScope>
			<biblScope unit="page" from="989" to="993" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Management of recurrent vulvovaginal candidosis as a chronic illness</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">G</forename><surname>Donders</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Bellen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gynecol Obstet Invest</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="306" to="321" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Vulvovaginal candidiasis: clinical manifestations, risk factors, management algorithm</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">O</forename><surname>Eckert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Hawes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Stevens</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">92</biblScope>
			<biblScope unit="page" from="757" to="765" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Signs of chronic stress in women with recurrent candida vulvovaginitis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Ehrström</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kornfeld</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Thuresson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">193</biblScope>
			<biblScope unit="page" from="1376" to="1381" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Probiotics for prevention of recurrent vulvovaginal candidiasis: a review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Falagas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">I</forename><surname>Betsi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Athanasiou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">A Antimicrob Chemother</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="266" to="272" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Repeated vulvovaginal fungal infections cause persistent pain in a mouse model of vulvodynia</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Farmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Taylor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Bailey</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sci Transl Med</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="101" to="191" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Scanning electron microscope study of Candida albicans, invasion of cultural human cervical epithelial cells</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Farrell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">F</forename><surname>Hawkins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">T</forename><surname>Ryder</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sabouraudia</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="251" to="254" />
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">Over-the-counter antifungal drug misuse associated with patient-diagnosed vulvovaginal candidiasis</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">D</forename><surname>Ferris</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Nyirjesy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">99</biblScope>
			<biblScope unit="page" from="419" to="425" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Human lectin-1 deficiency and mucocutaneous fungal infections</title>
		<author>
			<persName><forename type="first">B</forename><surname>Ferwerda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Ferwerda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">S</forename><surname>Platinga</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="1760" to="1767" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Immunity in vaginal candidiasis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Fidel</surname></persName>
		</author>
		<author>
			<persName><surname>Jr</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="107" to="111" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans</title>
		<author>
			<persName><surname>Fidel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">A</forename><surname>Vazquez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="80" to="96" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">The value of chronic suppressive therapy with itraconazole versus clotrimazole in women with recurrent vaginal candidiasis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Fong</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genitourin Med</title>
		<imprint>
			<biblScope unit="volume">68</biblScope>
			<biblScope unit="page" from="374" to="377" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">The epidemiology of vulvovaginal candidiasis: risk factors</title>
		<author>
			<persName><forename type="first">B</forename><surname>Foxman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Public Health</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="329" to="331" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Prevalence of recurrent vulvovaginal candidiasis in 5 European countries and the United States: results from an internet panel survey</title>
		<author>
			<persName><forename type="first">B</forename><surname>Foxman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Muraglia</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Dietz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Low Genit Tract Dis</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Topical antiseptics as an alternative in the treatment of acute vulvovaginal candidosis</title>
		<author>
			<persName><forename type="first">K</forename><surname>Friese</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Neumann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Siebert</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gynecol Obstet</title>
		<imprint>
			<biblScope unit="volume">268</biblScope>
			<biblScope unit="page" from="194" to="197" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Antimicrobial topical agents used in the vagina</title>
		<author>
			<persName><forename type="first">B</forename><surname>Frey Tirri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Probl Dermatol</title>
		<imprint>
			<biblScope unit="volume">40</biblScope>
			<biblScope unit="page" from="36" to="47" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Randomized study over 13 cycles to assess the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on carbohydrate metabilism</title>
		<author>
			<persName><forename type="first">U</forename><surname>Gaspard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Scheen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Contraception</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="423" to="429" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">Vaginal heat shock protein expression in symptom-free women with history of recurrent vulvovaginitis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Geraldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Neuer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">L</forename><surname>Korneeva</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">180</biblScope>
			<biblScope unit="page" from="524" to="529" />
			<date type="published" when="1999">1999</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<monogr>
		<title level="m" type="main">Pathogenecity determinants of Candida mycoses</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ghannoum</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Abu-El</forename><surname>Teen</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1990">1990</date>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="265" to="282" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Potential role of phospholipases in virulence and fungal pathogenesis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Ghannoum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Microbiol Rev</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="122" to="143" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Species-specific prevalence of vaginal candidiasis amoung patients with diabetes mellitus and its relation to their glycaemic status</title>
		<author>
			<persName><forename type="first">R</forename><surname>Goswami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Dadhwal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Tejaswi</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="162" to="166" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Pattern of Candida species isolated from patients with diabetes mellitus and vulvovaginal candidiasis and their response to single dose oral fluconazole therapy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Goswami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Goswami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Banerjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">52</biblScope>
			<biblScope unit="page" from="111" to="117" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b54">
	<analytic>
		<title level="a" type="main">Asymptomatic trichomonas and candida colonization and pregnancy outcome</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">H</forename><surname>Hay</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">E</forename><surname>Czeizel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Best Pract Res Clin Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="403" to="409" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b55">
	<analytic>
		<title level="a" type="main">Prevalence and management of non-albicans vaginal candidiasis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Hettiarachchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Ashbee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sex Transm Infect</title>
		<imprint>
			<biblScope unit="volume">86</biblScope>
			<biblScope unit="page" from="99" to="100" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b56">
	<analytic>
		<title level="a" type="main">Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis</title>
		<author>
			<persName><forename type="first">E</forename><surname>Hilton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">D</forename><surname>Isenberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Alperstein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="353" to="357" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b57">
	<analytic>
		<title level="a" type="main">Self-reported yeast symptoms compared with clinical wet mount analysis and vaginal yeast culture in a specialty clinic setting</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">E</forename><surname>Hoffstetter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Barr</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lefevre</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Reprod Med</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="402" to="406" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b58">
	<analytic>
		<title level="a" type="main">Yeast infections -human genetics in the rise</title>
		<author>
			<persName><forename type="first">S</forename><surname>Holland</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Vinh</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">361</biblScope>
			<biblScope unit="page" from="1798" to="1801" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b59">
	<analytic>
		<title level="a" type="main">Role of mannose-binding lectin in the innate defense against Candida albicans: enhancement of complement activation, but lack of opsonic function, in phagocytosis by human dendritic cells</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">K</forename><surname>Ip</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">L</forename><surname>Lan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Inf Dis</title>
		<imprint>
			<biblScope unit="volume">190</biblScope>
			<biblScope unit="page" from="632" to="640" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b60">
	<analytic>
		<title level="a" type="main">Utilisation of siderophores by Candida albicans</title>
		<author>
			<persName><forename type="first">A</forename><surname>Ismail</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Lupan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycopath</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page" from="109" to="113" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b61">
	<analytic>
		<title level="a" type="main">Prevention and treatment of vulvovaginal candidosis using exogenous lactobacilli</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Jeavons</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Obstet Gynecol Neonatal Nurs</title>
		<imprint>
			<biblScope unit="volume">32</biblScope>
			<biblScope unit="page" from="287" to="296" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b62">
	<analytic>
		<title level="a" type="main">C-type lectin Langerhans is a beta-glucan receptor on human Langerhans cells that recognize opportunistic and pathogenic fungi</title>
		<author>
			<persName><forename type="first">De</forename><surname>Jong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Vriend</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">E</forename><surname>Theelen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Immunol</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1216" to="1225" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b63">
	<analytic>
		<title level="a" type="main">Prospective randomised controlled trial of an infection screening program to reduce the rate of preterm delivery</title>
		<author>
			<persName><forename type="first">H</forename><surname>Kiss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Petricevicz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Husslein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">329</biblScope>
			<biblScope unit="page" from="371" to="375" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b64">
	<analytic>
		<title level="a" type="main">Herstellung eines autologen membrangebundenen Candida-Antigens und in-vitro-Untersuchungen zu seinen immunologischen Reaktionen</title>
		<author>
			<persName><forename type="first">H</forename><surname>Koldowsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kariger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Metzner G, Weissenbacher ER, Hrsg. Candida-Infektionen des weiblichen Genitaltraktes</title>
				<imprint>
			<date type="published" when="1999">1999</date>
			<biblScope unit="page" from="25" to="32" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b65">
	<analytic>
		<title level="a" type="main">Voraussetzungen für eine effektive Therapie chronisch rezidivierender Vaginalkandidosen</title>
		<author>
			<persName><forename type="first">V</forename><surname>Kunzelmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Tietz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Roßner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">39</biblScope>
			<biblScope unit="page" from="65" to="72" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
	<note>Suppl. 1</note>
</biblStruct>

<biblStruct xml:id="b66">
	<analytic>
		<title level="a" type="main">The glyzolate cycle enzyme activities in the pathogenitic isolates of Candida albicans obtained from HIV/AIDS, diabetic and burn patients</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">A</forename><surname>Lattif</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Prasard</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="85" to="89" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b67">
	<analytic>
		<title level="a" type="main">Prevalence and risk factors for vaginal Candida colonization in women with type I and type 2 diabetes</title>
		<author>
			<persName><forename type="first">E</forename><surname>De Leon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">J</forename><surname>Jacober</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Infect Dis</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="1" to="6" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b68">
	<analytic>
		<title level="a" type="main">Biased genotype distributions of Candida albicans strains associated with vulvovaginal candidosis and candidal balanoposthitis in China</title>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Fan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><forename type="middle">P</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Infect Dis</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1119" to="1125" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b69">
	<analytic>
		<title level="a" type="main">Terminologie der Humanmykosen</title>
		<author>
			<persName><forename type="first">W</forename><surname>Loeffler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mykosen</title>
		<imprint>
			<biblScope unit="volume">26</biblScope>
			<biblScope unit="page">346</biblScope>
			<date type="published" when="1983">1983</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b70">
	<analytic>
		<title level="a" type="main">Accuracy of the clinical diagnosis of vaginitis compared with a DNA probe labaratory standard</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">K</forename><surname>Lowe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">L</forename><surname>Neal</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Ryan-Wenger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">113</biblScope>
			<biblScope unit="page" from="89" to="95" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b71">
	<analytic>
		<title level="a" type="main">Potential role of probiotic bacteria in the treatment and prevention of localised candidosis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Mailänder-Sánchez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wagener</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">55</biblScope>
			<biblScope unit="page" from="17" to="26" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b72">
	<analytic>
		<title level="a" type="main">Effect of Lactobacillus rhamsosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and incluce inflammation</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Martinez</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Seney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Summers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Microbiol Immunol</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="487" to="495" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b73">
	<analytic>
		<title level="a" type="main">Prospective assessment of pregnancy outcome after first-trimester exposure to fluconazole</title>
		<author>
			<persName><forename type="first">P</forename><surname>Mastroiacovo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Mazzone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">D</forename><surname>Botto</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="1645" to="1650" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b74">
	<analytic>
		<title level="a" type="main">Prevalence of vaginal colonization by drug-resistent candida species in college-age women with previous exposure to over-the-counter azole antifungals</title>
		<author>
			<persName><forename type="first">B</forename><surname>Mathema</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Cross</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Dun</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Inf Dis</title>
		<imprint>
			<biblScope unit="volume">33</biblScope>
			<biblScope unit="page" from="E23" to="E27" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b75">
	<analytic>
		<title level="a" type="main">Die Salzsäure-Toleranz von Candida albicans</title>
		<author>
			<persName><forename type="first">W</forename><surname>Meinhof</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mykosen</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="339" to="347" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b76">
	<analytic>
		<title level="a" type="main">Die Torulopsidose in der Frauenheilkunde</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Geburtsh Frauenheilk</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="583" to="586" />
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b77">
	<analytic>
		<title level="a" type="main">Azoles in the Therapy of vaginal Candidosis</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Sterol Biosynthesis Inhibitors. Chichester: Ellis Horwood</title>
				<editor>
			<persName><forename type="first">D</forename><surname>Berg</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><surname>Plempel</surname></persName>
		</editor>
		<imprint>
			<biblScope unit="volume">1988</biblScope>
			<biblScope unit="page" from="480" to="506" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b78">
	<analytic>
		<title level="a" type="main">Investigations by cell-mediated immunologic tests of therapeutic trials with thymopentin in vaginal mycoses</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Koldovsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Inf Dis Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page" from="225" to="231" />
			<date type="published" when="1996">1996</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b79">
	<analytic>
		<title level="a" type="main">Vergleich der Stammspezifität von Hefepilzen verschiedener Lokalisationen bei Frauen mit Vaginalcandidosen und deren Partnern</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gutschmidt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Gantenberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="22" to="25" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>Suppl. 2</note>
</biblStruct>

<biblStruct xml:id="b80">
	<analytic>
		<title level="a" type="main">A clinical multi-center-study comparing afficacy and tolerability of topical combination therapy with Clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Krauss</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Fladung</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="136" to="142" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b81">
	<analytic>
		<title level="a" type="main">Vaginal colonisation with Candida species with special focus on Candida dubliniensis. A prospective study</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Niemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tintelnot</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Geburtsh Frauenheilk</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1132" to="1137" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b82">
	<monogr>
		<title level="m" type="main">AWMF-Guideline 013/004 (S1)</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Seebacher</surname></persName>
		</author>
		<author>
			<persName><surname>Vulvovaginalkandidose</surname></persName>
		</author>
		<imprint>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b83">
	<monogr>
		<title level="m" type="main">Zervizitis und Salpingitis. 2. Aufl. Heidelberg</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><surname>Vaginose</surname></persName>
		</author>
		<author>
			<persName><surname>Vaginitis</surname></persName>
		</author>
		<imprint>
			<publisher>Springer</publisher>
			<biblScope unit="page">2006</biblScope>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b84">
	<monogr>
		<title level="m" type="main">Antimykotische Therapie der vaginalen Hefepilz-Kolonisation von Schwangeren zur Verhütung von Kandidamykosen beim Neugeborenen</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Spitzbart</surname></persName>
		</author>
		<idno>015/042</idno>
		<imprint>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b85">
	<analytic>
		<title level="a" type="main">Die Vakzination mit inaktivierten Laktobazillen oder Heliotherapie kann die Lebensqualität von Frauen mit chronisch rezidivierender vulvovaginaler Kandidose verbessern. -Eine prospektive, 3-armige randomisierte Studie</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Birkner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Geburtsh Frauenheilk</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="767" to="772" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b86">
	<analytic>
		<title level="a" type="main">Three-day combination treatment for vulvovaginal Candidosis with 200 mg clotrimazol vaginal suppositories and clotrimazol cream for the vulva is significantly better than treatment with vaginal suppositories alone -an earlier, multi-centre, placebo-controlled double blind study</title>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Schlegelmilch</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Geburtsh Frauenheilk</title>
		<imprint>
			<biblScope unit="volume">74</biblScope>
			<biblScope unit="page" from="355" to="360" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b87">
	<analytic>
		<title level="a" type="main">Stress as a cause of chronic recurrent vulvovaginal candidosis and the effectiveness of the conventional antimycotic therapy</title>
		<author>
			<persName><forename type="first">H</forename><surname>Meyer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Göttlicher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="202" to="209" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b88">
	<analytic>
		<title level="a" type="main">Use of fluconazole during pregnancy and risk of birth defects</title>
		<author>
			<persName><forename type="first">D</forename><surname>Molgaard-Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Pasternak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Hviid</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="830" to="839" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b89">
	<analytic>
		<title level="a" type="main">Candida albicans allergen immunotherapy in recurrent vaginal candidiasis</title>
		<author>
			<persName><forename type="first">Psa</forename><surname>Moraes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>De Lima Goiaba</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">A</forename><surname>Taketoni</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Invest Allergol Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page" from="305" to="309" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b90">
	<analytic>
		<title level="a" type="main">Quantitative Untersuchungen über die Döderlein-Flora gesunder sowie mykosekranker Probandinnen unter lokaler Isoconazol-Nitrat-Therapie</title>
		<author>
			<persName><forename type="first">J</forename><surname>Müller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Nold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kubitza</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Seeliger HPR, Hrsg. Gyno -Travogen</title>
				<meeting><address><addrLine>Princeton</addrLine></address></meeting>
		<imprint>
			<biblScope unit="volume">1981</biblScope>
			<biblScope unit="page" from="81" to="93" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b91">
	<analytic>
		<title level="a" type="main">Diagnosis of vaginal discharge by wet mount microscopy: a simple and underrated method</title>
		<author>
			<persName><forename type="first">I</forename><surname>Mylonas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Bergauer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol Surv</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="359" to="368" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b92">
	<analytic>
		<title level="a" type="main">Candida albicans proteinases and host/pathogen interactions</title>
		<author>
			<persName><forename type="first">J</forename><surname>Naglik</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Albrecht</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Bader</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cellular Microbiology</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="page" from="915" to="926" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b93">
	<analytic>
		<title level="a" type="main">Association between atopy and recurrent vaginal candidosis</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">A</forename><surname>Neves</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">P</forename><surname>Carvallho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>De Oliveira</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Immunol</title>
		<imprint>
			<biblScope unit="volume">142</biblScope>
			<biblScope unit="page" from="167" to="171" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b94">
	<analytic>
		<title level="a" type="main">Ciclopirox olamine treatment affects the expression pattern of metabolism proteins, and drug resistance factors</title>
		<author>
			<persName><forename type="first">M</forename><surname>Niewerth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kunze</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Seibold</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="1805" to="1817" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b95">
	<analytic>
		<title level="a" type="main">Oral versus intra-vaginal imidazole and triazole anti-fungal treatment of uncomplicated vulvovaginal candidiasis (thrush)</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nurbhai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Grimshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Watson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">D002845</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b96">
	<analytic>
		<title level="a" type="main">Chronic fungal vaginitis: the value of cultures</title>
		<author>
			<persName><forename type="first">P</forename><surname>Nyirjesy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Seeney</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Grody</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">173</biblScope>
			<biblScope unit="page" from="820" to="823" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b97">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">P</forename><surname>Nyirjesy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Alexander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Weitz</surname></persName>
		</author>
		<author>
			<persName><surname>Vaginal</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infect Dis Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="37" to="41" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b98">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Odds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Candidosis</forename><surname>Candida</surname></persName>
		</author>
		<imprint>
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
	<note>2nd ed. Bailliére Tindall: WB Saunders</note>
</biblStruct>

<biblStruct xml:id="b99">
	<analytic>
		<title level="a" type="main">Nomenclature of fungal diseases: a report and recommendations from a sub-Committee of the International Society for Human and Animal Mycology (ISHAM)</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">C</forename><surname>Odds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Arai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Disalvo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Med Vet Mycol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="1" to="10" />
			<date type="published" when="1992">1992</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b100">
	<analytic>
		<title level="a" type="main">A 5-year (2000-2004) epidemiological survey of Candida and non-candida yeasts species causing vulvovaginal candidiasis in Graz</title>
		<author>
			<persName><forename type="first">A</forename><surname>Paulitsch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Weger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Ginter-Hanselmayer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">49</biblScope>
			<biblScope unit="page" from="471" to="475" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b101">
	<analytic>
		<title level="a" type="main">Treatment of non-albicans candida vaginitis with amphotericin B vaginal suppositories</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Phillips</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">192</biblScope>
			<biblScope unit="page" from="2009" to="2012" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b102">
	<analytic>
		<title level="a" type="main">Not thrush again!&quot; Womenʼs experience of post-antibiotic vulvovaginitis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Pirotta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Gunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chondros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med J Aust</title>
		<imprint>
			<biblScope unit="volume">179</biblScope>
			<biblScope unit="page" from="43" to="46" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b103">
	<analytic>
		<title level="a" type="main">Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial</title>
		<author>
			<persName><forename type="first">M</forename><surname>Pirotta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Gunn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Chondros</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMJ</title>
		<imprint>
			<biblScope unit="volume">329</biblScope>
			<biblScope unit="page" from="548" to="551" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b104">
	<analytic>
		<title level="a" type="main">Genital Candida species detected in samples from women in Melbourne, Australia, before and after treatment with antibiotics</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">V</forename><surname>Pirotta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Garland</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">44</biblScope>
			<biblScope unit="page" from="3213" to="3217" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b105">
	<analytic>
		<title level="a" type="main">Itraconazole vs. fluconazole for the treatment of uncomplicated acute vaginal and vulvovaginal candidiasis in nonpregnant women: a metaanalysis of randomised controlled trials</title>
		<author>
			<persName><forename type="first">E</forename><surname>Pitsoni</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Lavazzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Falagas</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">198</biblScope>
			<biblScope unit="page" from="153" to="160" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b106">
	<analytic>
		<title level="a" type="main">Pharmakokinetik der Imidazol-Antimykotika</title>
		<author>
			<persName><forename type="first">M</forename><surname>Plempel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mykosen</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="16" to="27" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b107">
	<analytic>
		<title level="a" type="main">Identification of a 173-estradiol-bindig protein in Candida albicans and Candida (Torulopsis) glabrata</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">L</forename><surname>Powell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Exp Mycology</title>
		<imprint>
			<biblScope unit="volume">8</biblScope>
			<biblScope unit="page">304</biblScope>
			<date type="published" when="1984">1984</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b108">
	<analytic>
		<title level="a" type="main">Evaluation of the efficacy and speed of action of sertoconazole nitrate suppository and cream combined treatment for vulvovaginal candidiasis</title>
		<author>
			<persName><forename type="first">C</forename><surname>Quereux</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Gelas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Chevallier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gynecol Obstet Fertil</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="238" to="244" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b109">
	<analytic>
		<title level="a" type="main">Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Ray</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Goswami</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Bomerjee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Care</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="312" to="317" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b110">
	<analytic>
		<title level="a" type="main">Systemic and mucosal immunization with Candida albicans hsp90 elicits hsp90-specific humoral response in vaginal mucosa which is further enhanced during experimental vaginal candidiasis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Raska</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Belakova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Horynova</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Mycol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="411" to="420" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b111">
	<analytic>
		<title level="a" type="main">Candida transmission and sexual behaviour as risk for a repeated episode of Candida vulvovaginitis</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Reed</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Zazone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">L</forename><surname>Pierson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Womens Health (Larchmt)</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="979" to="989" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b112">
	<analytic>
		<title level="a" type="main">Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Richter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">P</forename><surname>Galask</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Messer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="2155" to="2162" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b113">
	<analytic>
		<title level="a" type="main">Recurrent allergic vulvo-vaginitis treatment with Candida albicans allergen immunotherapy</title>
		<author>
			<persName><forename type="first">D</forename><surname>Rigg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Miller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Metzger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">162</biblScope>
			<biblScope unit="page" from="332" to="336" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b114">
	<analytic>
		<title level="a" type="main">Pharmacokinetics of Azole Compounds</title>
		<author>
			<persName><forename type="first">W</forename><surname>Ritter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m">Sterol Biosynthesis Inhibitors</title>
				<editor>
			<persName><forename type="first">D</forename><surname>Berg</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">M</forename><surname>Plempel</surname></persName>
		</editor>
		<meeting><address><addrLine>Chichester</addrLine></address></meeting>
		<imprint>
			<publisher>Ellis Horwood</publisher>
			<biblScope unit="volume">1988</biblScope>
			<biblScope unit="page" from="397" to="429" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b115">
	<analytic>
		<title level="a" type="main">Treatment of asymptomatic vaginal candidiasis in pregnancy to prevent preterm birth: an open-label pilot randomized controlled trial</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Roberts</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Rickard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Kotsiou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BMC Pregnancy Childbirth</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page">18</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b116">
	<analytic>
		<title level="a" type="main">Immunity to fungal infections</title>
		<author>
			<persName><forename type="first">L</forename><surname>Romani</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Immunol</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="275" to="288" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b117">
	<analytic>
		<title level="a" type="main">Candida africana and its closest relatives</title>
		<author>
			<persName><forename type="first">O</forename><surname>Romeo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Criseo</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="475" to="486" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b118">
	<analytic>
		<title level="a" type="main">Hyposensitisation in the management of recurring vaginal candidiasis</title>
		<author>
			<persName><forename type="first">N</forename><surname>Rosedale</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Browne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Allergy</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="250" to="253" />
			<date type="published" when="1979">1979</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b119">
	<analytic>
		<title level="a" type="main">Intermittent prophylactic treatment of recurrent vaginal candidiasis by postmenstrual application of a 500 mg clotrimazole vaginal tablet</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">C</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Milsom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Forssman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Genitourin Med</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope unit="page" from="357" to="360" />
			<date type="published" when="1990">1990</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b120">
	<analytic>
		<title level="a" type="main">Comparison of secretory proteinases from different strains of Candida albicans</title>
		<author>
			<persName><forename type="first">R</forename><surname>Rüchel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Fegeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Trost</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sabouraudia</title>
		<imprint>
			<biblScope unit="volume">20</biblScope>
			<biblScope unit="page" from="233" to="244" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b121">
	<analytic>
		<title level="a" type="main">Candida autovaccination in the treatment of vulvovaginal Candida infections</title>
		<author>
			<persName><forename type="first">K</forename><surname>Rusch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Schwiertz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Gynecol Obstet</title>
		<imprint>
			<biblScope unit="volume">96</biblScope>
			<biblScope unit="page">130</biblScope>
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b122">
	<analytic>
		<title level="a" type="main">Vulvovaginal candida in a young sexually active population: prevalence and association with oro-genital sex and frequent pain at intercourse</title>
		<author>
			<persName><forename type="first">E</forename><surname>Rylander</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A-L</forename><surname>Berglund</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Krassny</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sex Transm Infect</title>
		<imprint>
			<biblScope unit="volume">80</biblScope>
			<biblScope unit="page" from="54" to="57" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b123">
	<analytic>
		<title level="a" type="main">Two cases of vaginitis caused by Itraconazole -resistant Saccharomyces cerevisiae and review of recently published studies</title>
		<author>
			<persName><forename type="first">V</forename><surname>Savini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Catavitello</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Manua</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycopathologia</title>
		<imprint>
			<biblScope unit="volume">166</biblScope>
			<biblScope unit="page" from="47" to="50" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b124">
	<analytic>
		<title level="a" type="main">Veränderungen der Ultrastruktur von Candida albicans unter Einwirkung von Polyen-Antibiotika</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">D</forename><surname>Scheklakow</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">W</forename><surname>Deletorski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">A</forename><surname>Goldoa</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mykosen</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="140" to="152" />
			<date type="published" when="1980">1980</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b125">
	<analytic>
		<title level="a" type="main">Epidemiology and prevention of peripartal mycoses</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Schnell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Chemother</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="66" to="72" />
			<date type="published" when="1982">1982</date>
		</imprint>
	</monogr>
	<note>Suppl. I</note>
</biblStruct>

<biblStruct xml:id="b126">
	<analytic>
		<title level="a" type="main">Das Verhalten von Sprosspilzen am nicht verhornenden Plattenepithel</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Schnell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">H</forename><surname>Voigt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gynaekol</title>
		<imprint>
			<biblScope unit="volume">217</biblScope>
			<biblScope unit="page" from="377" to="382" />
			<date type="published" when="1974">1974</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b127">
	<analytic>
		<title level="a" type="main">Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy</title>
		<author>
			<persName><forename type="first">Z</forename><surname>Shahid</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diagn Microbiol Infect Dis</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="354" to="356" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b128">
	<analytic>
		<title level="a" type="main">Multilocus sequence typing of Candida africana from patients with vulvovaginal candidiasis in New Delhi</title>
		<author>
			<persName><forename type="first">C</forename><surname>Sharma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Muralidhar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">57</biblScope>
			<biblScope unit="page" from="544" to="552" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b129">
	<analytic>
		<title level="a" type="main">Vaginitis due to candida krusei: epidemiology, clinical aspects, and therapy</title>
		<author>
			<persName><forename type="first">S</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Bhargava</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Inf Dis</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="1066" to="1070" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b130">
	<analytic>
		<title level="a" type="main">Management of recurrent vulvovaginal candidiasis with intermittent ketoconazole prophylaxis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope unit="page" from="435" to="440" />
			<date type="published" when="1985">1985</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b131">
	<analytic>
		<title level="a" type="main">Vaginitis due to Saccharomyces cereviseae: epidemiology, clinical aspects, and therapy</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Inf Dis</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="93" to="99" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b132">
	<analytic>
		<title level="a" type="main">Vulvovaginitis due to Candida glabrata. An emerging problem</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="18" to="21" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
	<note>Suppl. 2</note>
</biblStruct>

<biblStruct xml:id="b133">
	<analytic>
		<title level="a" type="main">Vulvovaginal candidosis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">369</biblScope>
			<biblScope unit="page" from="1961" to="1971" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b134">
	<analytic>
		<title level="a" type="main">Maintenance fluconazole therapy for recurrent vulvovaginal Candidiasis</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Harold</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Wiesenfeld</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">351</biblScope>
			<biblScope unit="page" from="876" to="883" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b135">
	<analytic>
		<title level="a" type="main">Adherence of Candida albicans to human vaginal and buccal epithelial cells</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">G</forename><surname>Myers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Kaye</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect Dis</title>
		<imprint>
			<biblScope unit="volume">143</biblScope>
			<biblScope unit="page" from="76" to="82" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b136">
	<analytic>
		<title level="a" type="main">Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Zervos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">D</forename><surname>Reed</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Antimicrob Agents Chemother</title>
		<imprint>
			<biblScope unit="volume">47</biblScope>
			<biblScope unit="page" from="34" to="38" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b137">
	<analytic>
		<title level="a" type="main">The serum levels of calcium, magnesium, iron and zinc in patients with recurrent vulvovaginal candidosis during attack, remission and in healthy controls</title>
		<author>
			<persName><forename type="first">J</forename><surname>Spacek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Jilek</surname></persName>
		</author>
		<author>
			<persName><surname>Buchtav</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mycoses</title>
		<imprint>
			<biblScope unit="volume">48</biblScope>
			<biblScope unit="page" from="391" to="395" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b138">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">A</forename><surname>Spinillo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Capuzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">O</forename><surname>Egbe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Torulopsis glabrata vaginitis. Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">85</biblScope>
			<biblScope unit="page" from="993" to="998" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b139">
	<analytic>
		<title level="a" type="main">Infection through structured polymicrobial Gardnerella biofilms (StPM-GB)</title>
		<author>
			<persName><forename type="first">A</forename><surname>Swidsinski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Loening-Baucke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Mendling</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Histol Histopathol</title>
		<imprint>
			<biblScope unit="volume">29</biblScope>
			<biblScope unit="page" from="567" to="587" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b140">
	<analytic>
		<title level="a" type="main">Candida albicans: the estrogen target for vaginal colonization</title>
		<author>
			<persName><forename type="first">W</forename><surname>Tarry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fisher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Shen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Surg Res</title>
		<imprint>
			<biblScope unit="volume">129</biblScope>
			<biblScope unit="page" from="278" to="282" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b141">
	<analytic>
		<title level="a" type="main">Therapy and prophylaxis of the opportunistic infections in HIV-infected patients: a guideline by the German and Austrian AIDS societies (DAIG/ÖAG) (AWMF 055/066)</title>
		<author>
			<persName><forename type="first">J</forename><surname>Thoden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Potthoff</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">R</forename><surname>Bogner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Infection</title>
		<imprint>
			<biblScope unit="volume">41</biblScope>
			<biblScope unit="page" from="S91" to="S115" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
	<note>Suppl. 2</note>
</biblStruct>

<biblStruct xml:id="b142">
	<analytic>
		<title level="a" type="main">Recurrent vulvovaginal candidiasis: vaginal epithelial cells susceptibility to Candida albicans adherence</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Thrumbore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Sobel</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Obstet Gynecol</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="810" to="812" />
			<date type="published" when="1986">1986</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b143">
	<analytic>
		<title level="a" type="main">Gezieltes Vorgehen gegen Problemkeime</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Tietz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Gyn Geburtsh</title>
		<imprint>
			<biblScope unit="page" from="41" to="44" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b144">
	<analytic>
		<title/>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Tietz</surname></persName>
		</author>
		<author>
			<persName><surname>Candida</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pathogenität und Stand der Dinge. Hautarzt</title>
		<imprint>
			<biblScope unit="volume">63</biblScope>
			<biblScope unit="page" from="868" to="871" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b145">
	<analytic>
		<title level="a" type="main">Single-dose miconazole nitrate vaginal ovule in the treatment of vulvovaginal candidiasis: two single-blind, controlled studies versus miconazole nitrate 100 mg cream for 7 days</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Upmalis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">L</forename><surname>Cone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Lamia</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J. Womens Health Gend Based Med</title>
		<imprint>
			<biblScope unit="volume">9</biblScope>
			<biblScope unit="page" from="421" to="429" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b146">
	<analytic>
		<title level="a" type="main">New approaches in the development of a vaccine for mucosal Candidiasis: progress and challenges</title>
		<author>
			<persName><forename type="first">A</forename><surname>Vecciarelli</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Pericolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pietrella</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Front Microbiol</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page">294</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b147">
	<analytic>
		<title level="a" type="main">Survey of vaginal flora-flora Candida species isolates from women of different age groups by use of species-specific PCR detection</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Vermitsky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Self</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">G</forename><surname>Chadwick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Microbiol</title>
		<imprint>
			<biblScope unit="volume">46</biblScope>
			<biblScope unit="page" from="1501" to="1503" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b148">
	<analytic>
		<title level="a" type="main">Doppelblind-Vergleichsstudie mit Ciclopyroxolamin-und Miconazol-Vaginalcreme bei vulvovaginaler Kandidose</title>
		<author>
			<persName><forename type="first">M</forename><surname>Wajnberg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wajnberg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mykosen</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="721" to="730" />
			<date type="published" when="1981">1981</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b149">
	<analytic>
		<title level="a" type="main">Vaginal yeasts in the era of &quot;over the counter&quot; antifungals</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Walker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Reynolds</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Ashbee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Sex Transm Infect</title>
		<imprint>
			<biblScope unit="volume">76</biblScope>
			<biblScope unit="page" from="437" to="238" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b150">
	<analytic>
		<title level="a" type="main">Oval versus intravaginal imidazole and triazole antifungal treatment of uncomplicated Candidiasis (thrush): a systemic review</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Watson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Grimshaw</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">M</forename><surname>Bond</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJOG</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="85" to="89" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b151">
	<analytic>
		<title level="a" type="main">Relationship between recurrent vulvovaginal candidosis and immune mediators in vaginal fluid</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Weissenbacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Witkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Gingelmaier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Obstet Gynecol Reprod Biol</title>
		<imprint>
			<biblScope unit="volume">144</biblScope>
			<biblScope unit="page" from="59" to="63" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b152">
	<analytic>
		<title level="a" type="main">Relationship between clinical diagnosis of recurrent vulvovaginal candidiasis and detection of Candida species by culture and polymerase chain reaction</title>
		<author>
			<persName><forename type="first">T</forename><surname>Weissenbacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Witkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Ledger</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arch Gynecol Obstet</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope unit="page" from="125" to="129" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b153">
	<analytic>
		<title level="a" type="main">Hormonal contraception decreases bacterial vaginosis but oral contraception may increase candidiasis: implications for HIV transmission</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">H</forename><surname>Van De Wijgert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Verwijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">N</forename><surname>Turner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">AIDS</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="2141" to="2153" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b154">
	<analytic>
		<title level="a" type="main">Recurrent vulvovaginal candidiasis; an overview of traditional and alternative therapies</title>
		<author>
			<persName><forename type="first">C</forename><surname>Wilson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Nurse Pract</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="24" to="29" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b155">
	<analytic>
		<title level="a" type="main">A localized vaginal allergic response in women with recurrent vaginitis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Witkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Jeremias</forename><forename type="middle">J</forename><surname>Ledger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Allergy Clin Immunol</title>
		<imprint>
			<biblScope unit="volume">81</biblScope>
			<biblScope unit="page" from="412" to="416" />
			<date type="published" when="1988">1988</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b156">
	<analytic>
		<title level="a" type="main">New insights into the immune pathogenesis of recurrent vulvovaginal candidiasis</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">S</forename><surname>Witkin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Giraldo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Linhares</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Gynecol Obstet</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="114" to="118" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b157">
	<analytic>
		<title level="a" type="main">Monthly itraconazole versus classic homeopathy for the treatment of recurrent vulvovaginal candidiasis: a randomised trial</title>
		<author>
			<persName><forename type="first">A</forename><surname>Witt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Kaufmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bitschnau</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">BJOG</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="1499" to="1505" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b158">
	<analytic>
		<title level="a" type="main">Immunotherapeutic approaches to enhance protective immunity against Candida vaginitis</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">L</forename><surname>Wozniak</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Palmer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Kutner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Med Mycol</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="589" to="601" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b159">
	<analytic>
		<title level="a" type="main">Effect of antibiotics on vulvovaginal candidiasis: a MetroNet study</title>
		<author>
			<persName><forename type="first">J</forename><surname>Xu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Schwartz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bartoces</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Board Fam Med</title>
		<imprint>
			<biblScope unit="volume">21</biblScope>
			<biblScope unit="page" from="261" to="208" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b160">
	<analytic>
		<title level="a" type="main">Topical treatment for vaginal candidiasis (thrush) in pregnancy</title>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">L</forename><surname>Young</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Jewell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cochrane Database Syst Rev</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">D000225</biblScope>
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b161">
	<analytic>
		<title level="a" type="main">Die Hormonspirale als Ursache für chronische Infektionen. Dissertation (Prof</title>
		<author>
			<persName><forename type="first">W</forename><surname>Von Zglinicki</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">HJ Tietz)</title>
		<imprint>
			<date type="published" when="2011">Charité; 2011</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
